A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer - Concepedia

Concepedia

Publication | Closed Access

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

226

Citations

35

References

2010

Year

Michael Friedländer, Kenneth C. Hancock, Danny Rischin, Mark Messing, Claude A. Stringer, Gemma M. Matthys, Bo Ma, Jeffrey P. Hodge, Joanne Lager

Gynecologic Oncology

Phase IiMedicineMetronomic TherapyGynecologyRecurrent Ovarian CancerCancer TreatmentOpen-label StudyOncologyRadiation OncologyGynecology OncologyOvarian Cancer

References

	Year	Citations

Page 1

Page 1